Trace is partnering with Unlearn as it advances plans for a clinical trial of its treatment candidate that targets the UNC13A ...
Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...
Columnist Kristin Neva says a couple days in the Florida sunshine, away from the demands of caregiving, did wonders for her ...
Taking statins to lower cholesterol does not affect survival outcomes for people with amyotrophic lateral sclerosis (ALS), researchers in Norway have found. In a study of ALS patients using national ...
Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, ...
The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...
I realize that the words “goals,” “improvement,” and “ALS” don’t always appear in the same sentence, but for me, they do. That’s because, over the past few years, I’ve followed a strategy of setting ...
SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results